Literature DB >> 1446679

Characterization of a nitric-oxide-catalysed ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase.

S Dimmeler1, B Brüne.   

Abstract

Auto-ADP-ribosylation of the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GraPDH) has recently been demonstrated to be dramatically stimulated in the presence of nitric oxide. In order to obtain insight into the sequence of events leading to ADP-ribosylation of GraPDH, we studied the target amino acid, the nucleotide cofactor requirement, pH dependency and the stoichiometry of the reaction. Basal as well as stimulated ADP-ribose transfer is inhibited by the SH-group alkylating reagent, N-ethylmaleimide. Furthermore, the radiolabel of auto-[32P]ADP-ribosylated GraPDH is removed by treatment with HgCl2, suggesting an ADP-ribose-cysteine bond. Several indirect and direct mechanistic considerations point to NAD+ as the only cofactor for the ADP-ribosylation reaction, excluding the possibility of a reaction sequence involving a NAD-glycohydrolase(s) followed by nonenzymatic ADP-ribose transfer to GraPDH. Optimal ADP-ribosylations were carried out at alkaline pH values using 10 microM free NAD+ as the sole nucleotide cofactor. Bovine serum albumin with an S-nitrosylated SH group can serve as a model of ADP-ribose transfer from NAD+ and suggests that the nitric-oxide-modified SH group (S-nitrosylated SH group) is a prerequisite for the reaction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446679     DOI: 10.1111/j.1432-1033.1992.tb17422.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Glyceraldehyde-3-phosphate dehydrogenase on the surface of group A streptococci is also an ADP-ribosylating enzyme.

Authors:  V Pancholi; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

Review 2.  Enzymatic and nonenzymatic ADP-ribosylation of cysteine.

Authors:  L J McDonald; J Moss
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

3.  Niacin metabolism and Parkinson's disease.

Authors:  Tetsuhito Fukushima
Journal:  Environ Health Prev Med       Date:  2005-01       Impact factor: 3.674

Review 4.  Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration.

Authors:  D Allan Butterfield; Sarita S Hardas; Miranda L Bader Lange
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Stimulation of endogenous ADP-ribosylation by brefeldin A.

Authors:  M A De Matteis; M Di Girolamo; A Colanzi; M Pallas; G Di Tullio; L J McDonald; J Moss; G Santini; S Bannykh; D Corda
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

Review 6.  Nitric oxide and NAD-dependent protein modification.

Authors:  L J McDonald; J Moss
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

7.  Lipopolysaccharide-induced change of ADP-ribosylation of a cytosolic protein in bone-marrow-derived macrophages.

Authors:  S Hauschildt; P Scheipers; W G Bessler
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

Review 8.  The biochemical pathways of central nervous system neural degeneration in niacin deficiency.

Authors:  Linshan Fu; Venkatesh Doreswamy; Ravi Prakash
Journal:  Neural Regen Res       Date:  2014-08-15       Impact factor: 5.135

Review 9.  Critical protein GAPDH and its regulatory mechanisms in cancer cells.

Authors:  Jin-Ying Zhang; Fan Zhang; Chao-Qun Hong; Armando E Giuliano; Xiao-Jiang Cui; Guang-Ji Zhou; Guo-Jun Zhang; Yu-Kun Cui
Journal:  Cancer Biol Med       Date:  2015-03       Impact factor: 4.248

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.